Study of Endostar Combined With TP Regimen for Esophageal Cancer
Status:
Unknown status
Trial end date:
2021-07-13
Target enrollment:
Participant gender:
Summary
a randomized controlled trial of endostar combined with TP regimen(liposomal
paclitaxel-carboplatin) for chemoradiotherapy in esophageal squamous cell carcinoma(Ⅱ-Ⅲ)
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital of Xi'an Jiaotong University